SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-005127
Filing Date
2023-03-30
Accepted
2023-03-30 17:01:41
Documents
80
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nrbo-20221231x10k.htm   iXBRL 10-K 2565013
2 EX-4.12 nrbo-20221231xex4d12.htm EX-4.12 27077
3 EX-10.42 nrbo-20221231xex10d42.htm EX-10.42 36958
4 EX-21.1 nrbo-20221231xex21d1.htm EX-21.1 4520
5 EX-23.1 nrbo-20221231xex23d1.htm EX-23.1 4266
6 EX-31.1 nrbo-20221231xex31d1.htm EX-31.1 15744
7 EX-32.1 nrbo-20221231xex32d1.htm EX-32.1 8560
8 GRAPHIC nrbo-20221231x10k001.jpg GRAPHIC 28463
9 GRAPHIC nrbo-20221231x10k002.jpg GRAPHIC 38563
10 GRAPHIC nrbo-20221231xex10d42002.jpg GRAPHIC 2531
  Complete submission text file 0001558370-23-005127.txt   9460613

Data Files

Seq Description Document Type Size
11 EX-101.SCH nrbo-20221231.xsd EX-101.SCH 65006
12 EX-101.CAL nrbo-20221231_cal.xml EX-101.CAL 53051
13 EX-101.DEF nrbo-20221231_def.xml EX-101.DEF 298658
14 EX-101.LAB nrbo-20221231_lab.xml EX-101.LAB 591550
15 EX-101.PRE nrbo-20221231_pre.xml EX-101.PRE 475849
74 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20221231x10k_htm.xml XML 1360665
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37809 | Film No.: 23781554
SIC: 2834 Pharmaceutical Preparations